Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases. Issue 13 (24th January 2020)

• Record Type: Journal Article
• Authors: Hayashi, Kenshi; Teramoto, Ryota; Nomura, Akihiro; Asano, Yoshihiro; Beerens, Manu; Kurata, Yasutaka; Kobayashi, Isao; Fujino, Noboru; Furusho, Hiroshi; Sakata, Kenji; Onoue, Kenji; Chiang, David Y; Kiviniemi, Tuomas O; Buys, Eva; Sips, Patrick; Burch, Micah L; Zhao, Yanbin; Kelly, Amy E; Namura, Masanobu; Kita, Yoshihito; Tsuchiya, Taketsugu; Kaku, Bunji; Oe, Kotaro; Takeda, Yuko; Konno, Tetsuo; Inoue, Masaru; Fujita, Takashi; Kato, Takeshi; Funada, Akira; Tada, Hayato; Hodatsu, Akihiko; Nakanishi, Chiaki; Sakamoto, Yuichiro; Tsuda, Toyonobu; Nagata, Yoji; Tanaka, Yoshihiro; Okada, Hirofumi; Usuda, Keisuke; Cui, Shihe; Saito, Yoshihiko; MacRae, Calum A; Takashima, Seiji; Yamagishi, Masakazu; Kawashiri, Masa-aki; Takamura, Masayuki;
• Is Part Of: Cardiovascular research. Volume 116:Issue 13(2020)
• Page Start: 2116
• Page End: 2130
• Publication Date: 2020-01-24
• Subjects: Cardiac conduction system disease -- Whole exome sequencing -- 2015 ACMG standards and guidelines -- CRISPR/Cas9-mediated gene knock-out in zebrafish -- Cellular electrophysiological study; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Periodicals; 616.1
• DOI: 10.1093/cvr/cvaa010
• Languages: English
• ISSNs: 0008-6363

Abstract

Abstract: Aims: The genetic cause of cardiac conduction system disease (CCSD) has not been fully elucidated. Whole-exome sequencing (WES) can detect various genetic variants; however, the identification of pathogenic variants remains a challenge. We aimed to identify pathogenic or likely pathogenic variants in CCSD patients by using WES and 2015 American College of Medical Genetics and Genomics (ACMG) standards and guidelines as well as evaluating the usefulness of functional studies for determining them. Methods and results: We performed WES of 23 probands diagnosed with early-onset (<65 years) CCSD and analysed 117 genes linked to arrhythmogenic diseases or cardiomyopathies. We focused on rare variants (minor allele frequency < 0.1%) that were absent from population databases. Five probands had protein truncating variants in EMD and LMNA which were classified as 'pathogenic' by 2015 ACMG standards and guidelines. To evaluate the functional changes brought about by these variants, we generated a knock-out zebrafish with CRISPR-mediated insertions or deletions of the EMD or LMNA homologs in zebrafish. The mean heart rate and conduction velocities in the CRISPR/Cas9-injected embryos and F2 generation embryos with homozygous deletions were significantly decreased. Twenty-one variants of uncertain significance were identified in 11 probands. Cellular electrophysiological study and in vivo zebrafish cardiac assay showed that two variants in KCNH2 and SCN5A, four variants in SCN10A, and one variant in MYH6 damaged each gene, which resulted in the change of the clinical significance of them from 'Uncertain significance' to 'Likely pathogenic' in six probands. Conclusion: Of 23 CCSD probands, we successfully identified pathogenic or likely pathogenic variants in 11 probands (48%). Functional analyses of a cellular electrophysiological study and in vivo zebrafish cardiac assay might be useful for determining the pathogenicity of rare variants in patients with CCSD. SCN10A may be one of the major genes responsible for CCSD.